307 related articles for article (PubMed ID: 27749002)
1. Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.
Nguyen GN; George LA; Siner JI; Davidson RJ; Zander CB; Zheng XL; Arruda VR; Camire RM; Sabatino DE
J Thromb Haemost; 2017 Jan; 15(1):110-121. PubMed ID: 27749002
[TBL] [Abstract][Full Text] [Related]
2. Altered cleavage of human factor VIII at the B-domain and acidic region 3 interface enhances expression after gene therapy in hemophilia A mice.
Nguyen GN; Lindgren JR; Seleme MC; Kafle S; Zander CB; Zheng XL; Sabatino DE
J Thromb Haemost; 2023 Aug; 21(8):2101-2113. PubMed ID: 37080538
[TBL] [Abstract][Full Text] [Related]
3. Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype.
Siner JI; Iacobelli NP; Sabatino DE; Ivanciu L; Zhou S; Poncz M; Camire RM; Arruda VR
Blood; 2013 May; 121(21):4396-403. PubMed ID: 23372167
[TBL] [Abstract][Full Text] [Related]
4. Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.
Siner JI; Samelson-Jones BJ; Crudele JM; French RA; Lee BJ; Zhou S; Merricks E; Raymer R; Nichols TC; Camire RM; Arruda VR
JCI Insight; 2016 Oct; 1(16):e89371. PubMed ID: 27734034
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.
Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM
Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
McIntosh J; Lenting PJ; Rosales C; Lee D; Rabbanian S; Raj D; Patel N; Tuddenham EG; Christophe OD; McVey JH; Waddington S; Nienhuis AW; Gray JT; Fagone P; Mingozzi F; Zhou SZ; High KA; Cancio M; Ng CY; Zhou J; Morton CL; Davidoff AM; Nathwani AC
Blood; 2013 Apr; 121(17):3335-44. PubMed ID: 23426947
[TBL] [Abstract][Full Text] [Related]
7. High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice.
Xu L; Mei M; Ma X; Ponder KP
J Thromb Haemost; 2007 Sep; 5(9):1805-12. PubMed ID: 17596134
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effects of platelet factor VIII on megakaryopoiesis: implications for a modified human FVIII for platelet-based gene therapy.
Greene TK; Lyde RB; Bailey SC; Lambert MP; Zhai L; Sabatino DE; Camire RM; Arruda VR; Poncz M
J Thromb Haemost; 2014 Dec; 12(12):2102-12. PubMed ID: 25287191
[TBL] [Abstract][Full Text] [Related]
9. Sustained expression of human factor VIII in mice using a parvovirus-based vector.
Chao H; Mao L; Bruce AT; Walsh CE
Blood; 2000 Mar; 95(5):1594-9. PubMed ID: 10688813
[TBL] [Abstract][Full Text] [Related]
10. Codon optimization of human factor VIII cDNAs leads to high-level expression.
Ward NJ; Buckley SM; Waddington SN; Vandendriessche T; Chuah MK; Nathwani AC; McIntosh J; Tuddenham EG; Kinnon C; Thrasher AJ; McVey JH
Blood; 2011 Jan; 117(3):798-807. PubMed ID: 21041718
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo.
Zhang W; Mao J; Shen Y; Zhang G; Shao Y; Ruan Z; Wang Y; Wu W; Wang X; Zhu J; Chen S; Xiao W; Xi X
Blood Cells Mol Dis; 2018 Nov; 73():47-54. PubMed ID: 30249384
[TBL] [Abstract][Full Text] [Related]
12. Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system.
Chavez CL; Keravala A; Chu JN; Farruggio AP; Cuéllar VE; Voorberg J; Calos MP
Hum Gene Ther; 2012 Apr; 23(4):390-8. PubMed ID: 22077817
[TBL] [Abstract][Full Text] [Related]
13. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A.
Evans GL; Morgan RA
Proc Natl Acad Sci U S A; 1998 May; 95(10):5734-9. PubMed ID: 9576953
[TBL] [Abstract][Full Text] [Related]
14. Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model.
Sabatino DE; Freguia CF; Toso R; Santos A; Merricks EP; Kazazian HH; Nichols TC; Camire RM; Arruda VR
Blood; 2009 Nov; 114(20):4562-5. PubMed ID: 19770361
[TBL] [Abstract][Full Text] [Related]
15. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice.
Peng B; Ye P; Blazar BR; Freeman GJ; Rawlings DJ; Ochs HD; Miao CH
Blood; 2008 Sep; 112(5):1662-72. PubMed ID: 18574023
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A.
García-Martín C; Chuah MK; Van Damme A; Robinson KE; Vanzieleghem B; Saint-Remy JM; Gallardo D; Ofosu FA; Vandendriessche T; Hortelano G
J Gene Med; 2002; 4(2):215-23. PubMed ID: 11933222
[TBL] [Abstract][Full Text] [Related]
17. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
[TBL] [Abstract][Full Text] [Related]
18. Comparison of factor VIII transgenes bioengineered for improved expression in gene therapy of hemophilia A.
Dooriss KL; Denning G; Gangadharan B; Javazon EH; McCarty DA; Spencer HT; Doering CB
Hum Gene Ther; 2009 May; 20(5):465-78. PubMed ID: 19222367
[TBL] [Abstract][Full Text] [Related]
19. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
[TBL] [Abstract][Full Text] [Related]
20. Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII.
Chen H; Shi M; Gilam A; Zheng Q; Zhang Y; Afrikanova I; Li J; Gluzman Z; Jiang R; Kong LJ; Chen-Tsai RY
Sci Rep; 2019 Nov; 9(1):16838. PubMed ID: 31727959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
